title: Low-Dose IL-2 In Vivo Treg Expansion Limits Rejection in Corneal Grafting.
authors.affiliation: 1 Centre for Kidney Research, The Children's Hospital at Westmead, University of Sydney, Westmead, New South Wales, Australia. 2 Centre for Transplantation and Renal Research, Westmead Millennium Institute for Medical Research, University of Sydney, Westmead, New South Wales, Australia.
authors.forename: Geoff Y
authors.initials: GY
authors.lastname: Zhang
authors.forename: Min
authors.initials: M
authors.lastname: Hu
authors.forename: Yuan Min
authors.initials: YM
authors.lastname: Wang
authors.forename: Stephen I
authors.initials: SI
authors.lastname: Alexander
mesh_terms: D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects*; D003315:Cornea / Q000187:drug effects* / Q000601:surgery*; D016039:Corneal Transplantation / Q000379:methods*; D006085:Graft Survival / Q000187:drug effects*; D007376:Interleukin-2 / Q000008:administration & dosage*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008297:Male; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects*
chemical_list: D007376:Interleukin-2